Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Intel Corp.

Start price
Target price
Perf. (%)
€8.60
17.09.24
€9.00
17.09.25
-9.88%
20.09.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
Turk Telekomunikasyon As

Start price
Target price
Perf. (%)
€2.14
18.09.24
€2.00
18.09.25
0.00%
20.09.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€0.90
19.09.24
€1.00
19.09.25
-2.24%
20.09.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Precision BioSciences Inc

Start price
Target price
Perf. (%)
€0.39
19.09.23
€2.81
19.09.24
-11.92%
20.09.24

D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€0.86
18.09.24
€1.00
18.09.25
4.86%
19.09.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Innocan Pharma Corp.

Start price
Target price
Perf. (%)
€0.26
18.09.23
€1.00
18.09.24
-37.77%
19.09.24

Differentiated customer and product portfolio
Leading role in innovation
Revenue growth > 30% per year expected
Higher risks for its business
buy
Turk Hava Yollari A.s.

Start price
Target price
Perf. (%)
€74.00
04.09.24
€75.00
04.09.25
-2.03%
18.09.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Turk Telekomunikasyon As

Start price
Target price
Perf. (%)
€2.20
05.09.24
€2.00
05.09.25
-2.73%
18.09.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€0.92
15.09.24
€1.00
15.09.25
-6.17%
18.09.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Technip Energies N.v.

Start price
Target price
Perf. (%)
€22.70
18.09.24
€45.00
-
18.09.24

Could be very worthwhile Investment >20% year
Intel Corp.

Start price
Target price
Perf. (%)
€7.25
05.09.24
€9.00
05.09.25
18.62%
17.09.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
Nucana Plc

Start price
Target price
Perf. (%)
€6.60
16.09.24
-
16.09.25
-34.55%
17.09.24

Good culture
Risky Investment
No Innovation
Xortx Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.74
03.09.24
-
03.09.25
-7.76%
17.09.24

Probably not worthwhile Investment
buy
Cliq Digital AG

Start price
Target price
Perf. (%)
€6.84
11.09.24
-
11.10.24
4.53%
16.09.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Siyata Mobile Inc.

Start price
Target price
Perf. (%)
€1.27
03.09.24
-
03.09.25
-18.11%
16.09.24

Could be worthwhile Investment >10% per year
buy
Technip Energies N.v.

Start price
Target price
Perf. (%)
€21.14
02.09.24
€43.00
02.09.25
2.74%
16.09.24

Could be very worthwhile Investment >20% year
buy
Dianthus Therapeutics Inc.

Start price
Target price
Perf. (%)
€11.14
16.09.23
-
16.09.24
136.98%
16.09.24

buy
Immatics N.v.

Start price
Target price
Perf. (%)
€10.59
08.09.24
€15.00
31.03.27
9.35%
16.09.24

Could be very worthwhile Investment >20% year
buy
Mereo Biopharma Group Ltd.

Start price
Target price
Perf. (%)
€3.81
23.06.24
€5.00
30.11.26
-1.31%
16.09.24

Could be very worthwhile Investment >20% year
buy
Cannovum Cannabis AG

Start price
Target price
Perf. (%)
€1.05
10.09.24
-
10.09.25
-9.05%
15.09.24

Probably not worthwhile Investment
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€1.56
17.04.24
€1.00
17.04.25
-41.27%
15.09.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Novo-nordisk As

Start price
Target price
Perf. (%)
€91.56
15.09.23
-
15.09.24
34.82%
15.09.24

buy
Novo-nordisk As

Start price
Target price
Perf. (%)
€91.56
15.09.23
-
15.09.24
34.82%
15.09.24

buy
Societe Bic S.a.

Start price
Target price
Perf. (%)
€29.80
02.09.24
-
02.09.25
-1.34%
14.09.24

Could be worthwhile Investment >10% per year
buy
Vaxcyte Inc.

Start price
Target price
Perf. (%)
€49.20
24.06.23
€70.00
31.12.26
109.35%
13.09.24

Could be very worthwhile Investment >20% year